市場調査レポート

商品コード

1771493

性感染症（STI）・膣炎用PCR検査の世界市場：市場規模・シェア・動向分析 (症状別・検査の種類別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)

STI And Vaginitis PCR Testing Market Size, Share & Trends Analysis Report By Condition (Sexually Transmitted Infections, Vaginal Infections), By Test Type (STI PCR Panels, Vaginitis PCR Panels), By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日: 2025年06月06日
発行: Grand View Research
ページ情報: 英文 179 Pages
納期: 2～10営業日

カスタマイズ可能

価格

Unprintable PDF & Excel (Single User License)

USD 5,950 883,099円

レポートPDF及びExcelを1名様のみがご利用頂けるライセンスです。テキスト等のコピー＆ペースト、印刷はできません。

Printable PDF & Excel (5-User License)

USD 6,950 1,031,519円

レポートPDF及びExcelを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。テキスト等のコピー＆ペースト、印刷は可能です。

Printable PDF & Excel (Enterprise License)

USD 8,950 1,328,359円

レポートの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF及びExcelのテキスト等のコピー＆ペースト、印刷は可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.42円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

性感染症・膣炎用PCR検査：市場動向

世界の性感染症（STI）・膣炎用PCR検査の市場規模は、2024年に6億6,097万米ドルと推計され、2025年から2030年にかけてCAGR 9.21％で成長し、2030年には11億1,190万米ドルに達すると予測されています。

この背景には、性感染症や膣感染症の世界の罹患率の上昇があります。

性と生殖に関する健康に対する一般市民の意識の高まりと、PCR検査などの高感度分子診断法に対する嗜好の高まりが、市場拡大の大きな原動力となっています。2023年のCDCのデータによると、米国では240万件以上の梅毒、淋病、クラミジアの症例が診断・報告されており、その内訳は梅毒が20万9,000件以上、淋病が60万件以上、クラミジアが160万件以上となっています。さらに、家庭用検査キットへのアクセスの拡大、マルチプレックスPCRアッセイの技術進歩、公衆衛生インフラへの投資の拡大が、予測期間中の市場成長をさらに促進すると予想されます。

開発途上地域では、主に不十分な医療インフラと限られたスクリーニングプログラムにより、STIと膣炎の有病率が特に急増しています。都市化、移住、リスクの高い性行為は、このような疾病負担の増加に寄与しています。これらの要因により、大量のサンプルを処理し、信頼性の高い結果を提供できる、アクセス可能で感度の高い診断ツールの必要性が高まっています。低レベルの病原体DNAまたはRNAを検出する能力を持つPCR検査は、これらの要求を効果的に満たし、このような地域全体の公衆衛生スクリーニングイニシアチブでますます採用されています。

新しいPCR診断検査に対する規制認可は、性感染症・膣炎用PCR検査業界の成長軌道に大きく影響します。米国食品医薬品局（FDA）、欧州医薬品庁（EMA）、その他の地域機関などの当局からの承認取得は、迅速な市場参入を促進し、医療提供者の信頼を構築します。複数のSTIや膣炎を引き起こす病原体を1回の検査で検出するマルチプレックスPCRキットの最近の承認は、診断プロセスを合理化し、臨床ワークフローの効率を高めます。これらの認可された製品は、品質と性能のベンチマークを設定し、広く採用されることを奨励しています。

市場連関の見通し
- 親市場の見通し
- 関連/付随市場の見通し
市場力学
- 市場促進要因の分析
- 市場抑制要因の分析
性感染症・膣炎用PCR検査市場：分析ツール
ビジネス環境分析
- 業界分析：ポーターのファイブフォース分析
- PESTEL分析

第4章性感染症・膣炎用PCR検査市場：症状別の推定・動向分析

市場シェア：症状別（2024年・2030年）
セグメントダッシュボード
世界の性感染症・膣炎用PCR検査市場：症状別の展望
市場規模の予測と動向分析（2018年・2030年）
- 性感染症（STI）
- 膣感染症

第5章性感染症・膣炎用PCR検査市場：検査の種類別の推定・動向分析

市場シェア：検査の種類別（2024年・2030年）
セグメントダッシュボード
世界の性感染症・膣炎用PCR検査市場：検査の種類別の展望
市場規模の予測と動向分析（2018年・2030年）
- STI用PCRパネル
- 膣炎用PCRパネル

第6章性感染症・膣炎用PCR検査市場：最終用途別の推定・動向分析

市場シェア：最終用途別（2024年・2030年）
セグメントダッシュボード
世界の性感染症・膣炎用PCR検査市場：最終用途別の展望
市場規模の予測と動向分析（2018年・2030年）
- 病院・診療所
- 診断検査室
- 在宅医療/在宅検査
- その他

第7章性感染症・膣炎用PCR検査市場：地域別の推定・動向分析

市場シェア：地域別（2024年・2030年）
市場ダッシュボード：地域別
世界市場のスナップショット：地域別
市場規模の予測と動向分析（2018年・2030年）
北米
- 米国
- カナダ
- メキシコ
欧州
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- ノルウェー
- スウェーデン
- デンマーク
- ポルトガル
- トルコ
- スロベニア
- エストニア
- スウェーデン
- フィンランド
- ラトビア
- リトアニア
- ポーランド
- ロシア
- ウクライナ
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- タイ
- マレーシア
- インドネシア
- ベトナム
- 台湾
- タイ
- モンゴル
ラテンアメリカ
- ブラジル
- アルゼンチン
- コロンビア
- チリ
- エクアドル
- ペルー
中東・アフリカ
- アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第8章競合情勢

最近の動向と影響分析：主要な市場参入企業別
企業/競合の分類
ベンダー情勢
- 主要企業の市場シェア分析（2024年）
- BD
- F. Hoffmann-La Roche Ltd.
- Hologic, Inc.
- Abbott
- Danaher Corporation（Cepheid）
- Seegene Inc.
- bioMerieux（BioFire Diagnostics）
- QIAGEN
- Thermo Fisher Scientific, Inc.
- DiaSorin SpA（Luminex）
- Sansure Biotech Inc.
- R-Biopharm AG
- altona Diagnostics GmbH
- CERTEST BIOTEC

図表

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Leading Market Players Anticipated to Witness Highest Growth
Table 4 Global STI and Vaginitis PCR Testing Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 6 Global STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 7 Global STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 8 North America STI and Vaginitis PCR Testing Market, By Country, 2018 - 2030 (USD Million)
Table 9 North America STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 10 North America STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 11 North America STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 12 U.S. STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 13 U.S. STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 14 U.S. STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 15 Canada STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 16 Canada STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 17 Canada STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 18 Mexico STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 19 Mexico STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 20 Mexico STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 21 Europe STI and Vaginitis PCR Testing Market, By Country, 2018 - 2030 (USD Million)
Table 22 Europe STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 23 Europe STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 24 Europe STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 25 UK STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 26 UK STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 27 UK STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 28 Germany STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 29 Germany STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 30 Germany STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 31 France STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 32 France STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 33 France STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 34 Italy STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 35 Italy STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 36 Italy STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 37 Spain STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 38 Spain STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 39 Spain STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 40 Denmark STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 41 Denmark STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 42 Denmark STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 43 Sweden STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 44 Sweden STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 45 Sweden STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 46 Norway STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 47 Norway STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 48 Norway STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 49 Portugal STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 50 Portugal STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 51 Portugal STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 52 Hungary STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 53 Hungary STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 54 Hungary STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 55 Turkey STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 56 Turkey STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 57 Turkey STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 58 Slovenia STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 59 Slovenia STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 60 Slovenia STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 61 Estonia STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 62 Estonia STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 63 Estonia STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 64 Finland STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 65 Finland STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 66 Finland STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 67 Latvia STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 68 Latvia STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 69 Latvia STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 70 Lithuania STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 71 Lithuania STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 72 Lithuania STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 73 Poland STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 74 Poland STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 75 Poland STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 76 Russia STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 77 Russia STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 78 Russia STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 79 Ukraine STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 80 Ukraine STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 81 Ukraine STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 82 Asia Pacific STI and Vaginitis PCR Testing Market, By Country, 2018 - 2030 (USD Million)
Table 83 Asia Pacific STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 84 Asia Pacific STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 85 Asia Pacific STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 86 Japan STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 87 Japan STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 88 Japan STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 89 China STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 90 China STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 91 China STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 92 India STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 93 India STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 94 India STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 95 South Korea STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 96 South Korea STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 97 South Korea STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 98 Australia STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 99 Australia STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 100 Australia STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 101 Thailand STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 102 Thailand STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 103 Thailand STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 104 Malaysia STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 105 Malaysia STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 106 Malaysia STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 107 Indonesia STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 108 Indonesia STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 109 Indonesia STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 110 Vietnam STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 111 Vietnam STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 112 Vietnam STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 113 Taiwan STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 114 Taiwan STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 115 Taiwan STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 116 Mongolia STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 117 Mongolia STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 118 Mongolia STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 119 Latin America STI and Vaginitis PCR Testing Market, By Country, 2018 - 2030 (USD Million)
Table 120 Latin America STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 121 Latin America STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 122 Latin America STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 123 Brazil STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 124 Brazil STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 125 Brazil STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 126 Argentina STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 127 Argentina STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 128 Argentina STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 129 Colombia STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 130 Colombia STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 131 Colombia STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 132 Chile STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 133 Chile STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 134 Chile STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 135 Ecuador STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 136 Ecuador STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 137 Ecuador STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 138 Peru STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 139 Peru STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 140 Peru STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 141 Middle East and Africa STI and Vaginitis PCR Testing Market, By Country, 2018 - 2030 (USD Million)
Table 142 Middle East and Africa STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 143 Middle East and Africa STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 144 Middle East & Africa STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 145 South Africa STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 146 South Africa STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 147 South Africa STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 148 Saudi Arabia STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 149 Saudi Arabia STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 150 Saudi Arabia STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 151 UAE STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 152 UAE STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 153 UAE STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)
Table 154 Kuwait STI and Vaginitis PCR Testing Market, By Condition, 2018 - 2030 (USD Million)
Table 155 Kuwait STI and Vaginitis PCR Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 156 Kuwait STI and Vaginitis PCR Testing Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 STI and vaginitis PCR testing market segment scope and definition
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2024)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter's five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 STI and Vaginitis PCR Testing market: Condition movement analysis
Fig. 17 STI and Vaginitis PCR Testing market: Condition segment dashboard
Fig. 18 STI and vaginitis PCR testing market Condition outlook: Key takeaways
Fig. 19 Sexually Transmitted Infections (STIs) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Chlamydia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Gonorrhea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Trichomoniasis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Herpes Simplex Virus (HSV-1 & HSV-2) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Human Papillomavirus (HPV) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Syphilis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Other market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Vaginal infections market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Bacterial Vaginosis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Vulvovaginal Candidiasis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Other market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 STI and Vaginitis PCR Testing market: Test Type movement analysis
Fig. 32 STI and vaginitis PCR testing market Test Type outlook: Key takeaways
Fig. 33 STI PCR panels market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Vaginitis PCR panels market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 STI and Vaginitis PCR Testing market: End use movement analysis
Fig. 36 STI and vaginitis PCR testing market End use outlook: Key takeaways
Fig. 37 Hospitals and Clinics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Diagnostic Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Homecare/At-home Testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Regional outlook, 2024 & 2030
Fig. 42 Regional market dashboard
Fig. 43 Regional marketplace: Key takeaways
Fig. 44 North America STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 45 U.S. STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 46 Canada STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 47 Mexico STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 48 Europe STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 49 UK STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 50 Germany STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 51 Spain STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 52 France STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 53 Italy STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 54 Denmark STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 55 Sweden STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 56 Norway STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 57 Portugal STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 58 Hungary STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 59 Turkey STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 60 Slovenia STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 61 Estonia STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 62 Finland STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 63 Latvia STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 64 Lithuania STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 65 Poland STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 66 Russia STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 67 Ukraine STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 68 Asia Pacific STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 69 Japan STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 70 China STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 71 India STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 72 South Korea STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 73 Australia STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 74 Thailand STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 75 Malaysia STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 76 Indonesia STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 77 Vietnam STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 78 Taiwan STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 79 Mongolia STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 80 Latin America STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 81 Brazil STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 82 Argentina STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 83 Colombia STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 84 Chile STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 85 Ecuador STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 86 Peru STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 87 MEA STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 88 Africa STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 89 Saudi Arabia STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 90 UAE STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 91 Kuwait STI and Vaginitis PCR Testing Market, 2018 - 2030 (USD Million)
Fig. 92 Heat map analysis
Fig. 93 Market differentiators

Product Code: GVR-4-68040-608-9

STI And Vaginitis PCR Testing Market Trends:

The global STI and vaginitis PCR testing market size was estimated at USD 660.97 million in 2024 and is projected to reach USD 1,111.9 million by 2030, growing at a CAGR of 9.21% from 2025 to 2030. This is attributed to the rising global incidence of sexually transmitted and vaginal infections.

Increasing public awareness of sexual and reproductive health, and the increasing preference for highly sensitive molecular diagnostic methods such as PCR testing, significantly drive the market expansion. According to CDC data in 2023, more than 2.4 million cases of syphilis, gonorrhea, and chlamydia were diagnosed and reported in the U.S. This total comprised over 209,000 cases of syphilis, more than 600,000 cases of gonorrhea, and upwards of 1.6 million cases of chlamydia. Additionally, expanding access to at-home testing kits, technological advancements in multiplex PCR assays, and greater investment in public health infrastructure are expected to further drive market growth over the forecast period.

Developing regions are witnessing particularly sharp increases in STIs and vaginitis prevalence, primarily due to inadequate healthcare infrastructure and limited screening programs. Urbanization, migration, and high-risk sexual practices contribute to this rising disease burden. These factors increase the need for accessible, sensitive diagnostic tools capable of handling high sample volumes and delivering reliable results. With its ability to detect low levels of pathogen DNA or RNA, PCR testing meets these demands effectively and is increasingly adopted in public health screening initiatives across such regions.

Regulatory approvals for new PCR diagnostic tests significantly impact the growth trajectory of the STI and vaginitis PCR testing industry. Obtaining approvals from authorities such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other regional bodies facilitates faster market access and builds confidence among healthcare providers. Recent approvals of multiplex PCR kits that detect multiple STIs and vaginitis-causing pathogens in a single test streamline the diagnostic process, enhancing clinical workflow efficiency. These authorized products set quality and performance benchmarks that encourage widespread adoption.

Global STI And Vaginitis PCR Testing Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global STI and vaginitis PCR testing market report based on condition, test type, end-use, and region:

Condition Outlook (Revenue, USD Million, 2018 - 2030)
Sexually Transmitted Infections (STIs)
- Chlamydia
- Gonorrhea
- Trichomoniasis
- Herpes Simplex Virus (HSV-1 & HSV-2)
- Human Papillomavirus (HPV)
- Syphilis
- Other
Vaginal Infections
- Bacterial Vaginosis
- Vulvovaginal Candidiasis
- Other
Test type Outlook (Revenue, USD Million, 2018 - 2030)
STI PCR Panels
Vaginitis PCR Panels
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals and Clinics
Diagnostic Laboratories
Homecare/At-home Testing
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Portugal
- Hungary
- Turkey
- Slovenia
- Norway
- Denmark
- Sweden
- Estonia
- Finland
- Latvia
- Lithuania
- Poland
- Russia
- Ukraine
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Malaysia
- Indonesia
- Vietnam
- Taiwan
- Mongolia
Latin America
- Brazil
- Argentina
- Colombia
- Chile
- Ecuador
- Peru
Middle East & Africa
- Saudi Arabia
- UAE
- Kuwait
- Africa

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Condition
- 1.2.2. Test Type
- 1.2.3. End Use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
1.5. Primary research
- 1.5.1. Details of primary research
  - 1.5.1.1. Data for primary interviews in North America
  - 1.5.1.2. Data for primary interviews in Europe
  - 1.5.1.3. Data for primary interviews in Asia Pacific
  - 1.5.1.4. Data for primary interviews in Latin America
  - 1.5.1.5. Data for Primary interviews in MEA
- 1.5.2. Information or Data Analysis
- 1.5.3. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Condition outlook
- 2.2.2. Test Type Outlook
- 2.2.3. End Use Outlook
- 2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. STI and vaginitis PCR testing Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Rising prevalence of STIs and vaginitis infections fuels market demand
  - 3.2.1.2. Regulatory approvals accelerate market adoption and innovation
  - 3.2.1.3. Technological advancements enhance accuracy and accessibility of PCR testing
  - 3.2.1.4. Growing awareness and screening programs boost early diagnosis rates
3.3. Market Restraint Analysis
3.4. STI and vaginitis PCR testing Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.2. PESTEL Analysis

Chapter 4. STI and vaginitis PCR testing Market: Condition Estimates & Trend Analysis

4.1. Condition Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. Global STI and vaginitis PCR testing Market by Condition Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.4.1. Sexually Transmitted Infections (STIs)
  - 4.4.1.1. STI's market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.1.2. Chlamydia
    - 4.4.1.2.1. Chlamydia market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.1.3. Gonorrhea
    - 4.4.1.3.1. Gonorrhea market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.1.4. Trichomoniasis
    - 4.4.1.4.1. Trichomoniasis market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.1.5. Herpes Simplex Virus (HSV-1 & HSV-2)
    - 4.4.1.5.1. HSV market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.1.6. Human Papillomavirus (HPV)
    - 4.4.1.6.1. HPV market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.1.7. Syphilis
    - 4.4.1.7.1. Syphilis market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.1.8. Other
    - 4.4.1.8.1. Other market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2. Vaginal Infections
  - 4.4.2.1. Vaginal infections market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.2.2. Bacterial Vaginosis
    - 4.4.2.2.1. Bacterial Vaginosis market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.2.3. Vulvovaginal Candidiasis
    - 4.4.2.3.1. Vulvovaginal Candidiasis market estimates and forecasts 2018 to 2030 (USD Million)
  - 4.4.2.4. Other
  - 4.4.2.5. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. STI and vaginitis PCR testing Market: Test Type Estimates & Trend Analysis

5.1. Test Type Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. Global STI and vaginitis PCR testing Market by Test Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.4.1. STI PCR Panels
  - 5.4.1.1. STI PCR panels market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2. Vaginitis PCR Panels

Chapter 6. STI and vaginitis PCR testing Market: End use Estimates & Trend Analysis

6.1. End Use Market Share, 2024 & 2030
6.2. Segment Dashboard
6.3. Global STI and vaginitis PCR testing Market by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.4.1. Hospitals and Clinics
  - 6.4.1.1. Hospitals and Clinics market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.2. Diagnostic Laboratories
  - 6.4.2.1. Diagnostic Laboratories market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.3. Homecare/At-home Testing
  - 6.4.3.1. Homecare/At-home Testing market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.4. Others
  - 6.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. STI and Vaginitis PCR Testing Market: Regional Estimates & Trend Analysis

7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts, Trend Analysis, 2018 to 2030:
7.5. North America
- 7.5.1. U.S.
  - 7.5.1.1. Key country dynamics
  - 7.5.1.2. Regulatory framework/ reimbursement structure
  - 7.5.1.3. Competitive scenario
  - 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.2. Canada
  - 7.5.2.1. Key country dynamics
  - 7.5.2.2. Regulatory framework/ reimbursement structure
  - 7.5.2.3. Competitive scenario
  - 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.3. Mexico
  - 7.5.3.1. Key country dynamics
  - 7.5.3.2. Regulatory framework/ reimbursement structure
  - 7.5.3.3. Competitive scenario
  - 7.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
- 7.6.1. UK
  - 7.6.1.1. Key country dynamics
  - 7.6.1.2. Regulatory framework/ reimbursement structure
  - 7.6.1.3. Competitive scenario
  - 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.2. Germany
  - 7.6.2.1. Key country dynamics
  - 7.6.2.2. Regulatory framework/ reimbursement structure
  - 7.6.2.3. Competitive scenario
  - 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.3. France
  - 7.6.3.1. Key country dynamics
  - 7.6.3.2. Regulatory framework/ reimbursement structure
  - 7.6.3.3. Competitive scenario
  - 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.4. Italy
  - 7.6.4.1. Key country dynamics
  - 7.6.4.2. Regulatory framework/ reimbursement structure
  - 7.6.4.3. Competitive scenario
  - 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.5. Spain
  - 7.6.5.1. Key country dynamics
  - 7.6.5.2. Regulatory framework/ reimbursement structure
  - 7.6.5.3. Competitive scenario
  - 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.6. Norway
  - 7.6.6.1. Key country dynamics
  - 7.6.6.2. Regulatory framework/ reimbursement structure
  - 7.6.6.3. Competitive scenario
  - 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.7. Sweden
  - 7.6.7.1. Key country dynamics
  - 7.6.7.2. Regulatory framework/ reimbursement structure
  - 7.6.7.3. Competitive scenario
  - 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.8. Denmark
  - 7.6.8.1. Key country dynamics
  - 7.6.8.2. Regulatory framework/ reimbursement structure
  - 7.6.8.3. Competitive scenario
  - 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.9. Portugal
  - 7.6.9.1. Key country dynamics
  - 7.6.9.2. Regulatory framework/ reimbursement structure
  - 7.6.9.3. Competitive scenario
  - 7.6.9.4. Portugal market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.10. Turkey
  - 7.6.10.1. Key country dynamics
  - 7.6.10.2. Regulatory framework/ reimbursement structure
  - 7.6.10.3. Competitive scenario
  - 7.6.10.4. Turkey market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.11. Slovenia
  - 7.6.11.1. Key country dynamics
  - 7.6.11.2. Regulatory framework/ reimbursement structure
  - 7.6.11.3. Competitive scenario
  - 7.6.11.4. Slovenia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.12. Estonia
  - 7.6.12.1. Key country dynamics
  - 7.6.12.2. Regulatory framework/ reimbursement structure
  - 7.6.12.3. Competitive scenario
  - 7.6.12.4. Estonia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.13. Sweden
  - 7.6.13.1. Key country dynamics
  - 7.6.13.2. Regulatory framework/ reimbursement structure
  - 7.6.13.3. Competitive scenario
  - 7.6.13.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.14. Finland
  - 7.6.14.1. Key country dynamics
  - 7.6.14.2. Regulatory framework/ reimbursement structure
  - 7.6.14.3. Competitive scenario
  - 7.6.14.4. Finland market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.15. Latvia
  - 7.6.15.1. Key country dynamics
  - 7.6.15.2. Regulatory framework/ reimbursement structure
  - 7.6.15.3. Competitive scenario
  - 7.6.15.4. Latvia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.16. Lithuania
  - 7.6.16.1. Key country dynamics
  - 7.6.16.2. Regulatory framework/ reimbursement structure
  - 7.6.16.3. Competitive scenario
  - 7.6.16.4. Lithuania market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.17. Poland
  - 7.6.17.1. Key country dynamics
  - 7.6.17.2. Regulatory framework/ reimbursement structure
  - 7.6.17.3. Competitive scenario
  - 7.6.17.4. Poland market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.18. Russia
  - 7.6.18.1. Key country dynamics
  - 7.6.18.2. Regulatory framework/ reimbursement structure
  - 7.6.18.3. Competitive scenario
  - 7.6.18.4. Russia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.19. Ukraine
  - 7.6.19.1. Key country dynamics
  - 7.6.19.2. Regulatory framework/ reimbursement structure
  - 7.6.19.3. Competitive scenario
  - 7.6.19.4. Ukraine market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia Pacific
- 7.7.1. Japan
  - 7.7.1.1. Key country dynamics
  - 7.7.1.2. Regulatory framework/ reimbursement structure
  - 7.7.1.3. Competitive scenario
  - 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.2. China
  - 7.7.2.1. Key country dynamics
  - 7.7.2.2. Regulatory framework/ reimbursement structure
  - 7.7.2.3. Competitive scenario
  - 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.3. India
  - 7.7.3.1. Key country dynamics
  - 7.7.3.2. Regulatory framework/ reimbursement structure
  - 7.7.3.3. Competitive scenario
  - 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.4. Australia
  - 7.7.4.1. Key country dynamics
  - 7.7.4.2. Regulatory framework/ reimbursement structure
  - 7.7.4.3. Competitive scenario
  - 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.5. South Korea
  - 7.7.5.1. Key country dynamics
  - 7.7.5.2. Regulatory framework/ reimbursement structure
  - 7.7.5.3. Competitive scenario
  - 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.6. Thailand
  - 7.7.6.1. Key country dynamics
  - 7.7.6.2. Regulatory framework/ reimbursement structure
  - 7.7.6.3. Competitive scenario
  - 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.7. Malaysia
  - 7.7.7.1. Key country dynamics
  - 7.7.7.2. Regulatory framework/ reimbursement structure
  - 7.7.7.3. Competitive scenario
  - 7.7.7.4. Malaysia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.8. Indonesia
  - 7.7.8.1. Key country dynamics
  - 7.7.8.2. Regulatory framework/ reimbursement structure
  - 7.7.8.3. Competitive scenario
  - 7.7.8.4. Indonesia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.9. Vietnam
  - 7.7.9.1. Key country dynamics
  - 7.7.9.2. Regulatory framework/ reimbursement structure
  - 7.7.9.3. Competitive scenario
  - 7.7.9.4. Vietnam market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.10. Taiwan
  - 7.7.10.1. Key country dynamics
  - 7.7.10.2. Regulatory framework/ reimbursement structure
  - 7.7.10.3. Competitive scenario
  - 7.7.10.4. Taiwan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.11. Thailand
  - 7.7.11.1. Key country dynamics
  - 7.7.11.2. Regulatory framework/ reimbursement structure
  - 7.7.11.3. Competitive scenario
  - 7.7.11.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.12. Mongolia
  - 7.7.12.1. Key country dynamics
  - 7.7.12.2. Regulatory framework/ reimbursement structure
  - 7.7.12.3. Competitive scenario
  - 7.7.12.4. Mongolia market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
- 7.8.1. Brazil
  - 7.8.1.1. Key country dynamics
  - 7.8.1.2. Regulatory framework/ reimbursement structure
  - 7.8.1.3. Competitive scenario
  - 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.2. Argentina
  - 7.8.2.1. Key country dynamics
  - 7.8.2.2. Regulatory framework/ reimbursement structure
  - 7.8.2.3. Competitive scenario
  - 7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.3. Colombia
  - 7.8.3.1. Key country dynamics
  - 7.8.3.2. Regulatory framework/ reimbursement structure
  - 7.8.3.3. Competitive scenario
  - 7.8.3.4. Colombia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.4. Chile
  - 7.8.4.1. Key country dynamics
  - 7.8.4.2. Regulatory framework/ reimbursement structure
  - 7.8.4.3. Competitive scenario
  - 7.8.4.4. Chile market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.5. Ecuador
  - 7.8.5.1. Key country dynamics
  - 7.8.5.2. Regulatory framework/ reimbursement structure
  - 7.8.5.3. Competitive scenario
  - 7.8.5.4. Ecuador market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.6. Peru
  - 7.8.6.1. Key country dynamics
  - 7.8.6.2. Regulatory framework/ reimbursement structure
  - 7.8.6.3. Competitive scenario
  - 7.8.6.4. Peru market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
- 7.9.1. Africa
  - 7.9.1.1. Key country dynamics
  - 7.9.1.2. Regulatory framework/ reimbursement structure
  - 7.9.1.3. Competitive scenario
  - 7.9.1.4. Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.2. Saudi Arabia
  - 7.9.2.1. Key country dynamics
  - 7.9.2.2. Regulatory framework/ reimbursement structure
  - 7.9.2.3. Competitive scenario
  - 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.3. UAE
  - 7.9.3.1. Key country dynamics
  - 7.9.3.2. Regulatory framework/ reimbursement structure
  - 7.9.3.3. Competitive scenario
  - 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.4. Kuwait
  - 7.9.4.1. Key country dynamics
  - 7.9.4.2. Regulatory framework/ reimbursement structure
  - 7.9.4.3. Competitive scenario
  - 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
- 8.3.1. Key company market share analysis, 2024
- 8.3.2. BD
  - 8.3.2.1. Company overview
  - 8.3.2.2. Financial performance
  - 8.3.2.3. Product benchmarking
  - 8.3.2.4. Strategic initiatives
- 8.3.3. F. Hoffmann-La Roche Ltd.
  - 8.3.3.1. Company overview
  - 8.3.3.2. Financial performance
  - 8.3.3.3. Product benchmarking
  - 8.3.3.4. Strategic initiatives
- 8.3.4. Hologic, Inc.
  - 8.3.4.1. Company overview
  - 8.3.4.2. Financial performance
  - 8.3.4.3. Product benchmarking
  - 8.3.4.4. Strategic initiatives
- 8.3.5. Abbott
  - 8.3.5.1. Company overview
  - 8.3.5.2. Financial performance
  - 8.3.5.3. Product benchmarking
  - 8.3.5.4. Strategic initiatives
- 8.3.6. Danaher Corporation (Cepheid)
  - 8.3.6.1. Company overview
  - 8.3.6.2. Financial performance
  - 8.3.6.3. Product benchmarking
  - 8.3.6.4. Strategic initiatives
- 8.3.7. Seegene Inc.
  - 8.3.7.1. Company overview
  - 8.3.7.2. Financial performance
  - 8.3.7.3. Product benchmarking
  - 8.3.7.4. Strategic initiatives
- 8.3.8. bioMerieux (BioFire Diagnostics)
  - 8.3.8.1. Company overview
  - 8.3.8.2. Financial performance
  - 8.3.8.3. Product benchmarking
  - 8.3.8.4. Strategic initiatives
- 8.3.9. QIAGEN
  - 8.3.9.1. Company overview
  - 8.3.9.2. Financial performance
  - 8.3.9.3. Product benchmarking
  - 8.3.9.4. Strategic initiatives
- 8.3.10. Thermo Fisher Scientific, Inc.
  - 8.3.10.1. Company overview
  - 8.3.10.2. Financial performance
  - 8.3.10.3. Product benchmarking
  - 8.3.10.4. Strategic initiatives
- 8.3.11. DiaSorin S.p.A (Luminex)
  - 8.3.11.1. Company overview
  - 8.3.11.2. Financial performance
  - 8.3.11.3. Product benchmarking
  - 8.3.11.4. Strategic initiatives
- 8.3.12. Sansure Biotech Inc.
  - 8.3.12.1. Company overview
  - 8.3.12.2. Financial performance
  - 8.3.12.3. Product benchmarking
  - 8.3.12.4. Strategic initiatives
- 8.3.13. R-Biopharm AG
  - 8.3.13.1. Company overview
  - 8.3.13.2. Financial performance
  - 8.3.13.3. Product benchmarking
  - 8.3.13.4. Strategic initiatives
- 8.3.14. altona Diagnostics GmbH
  - 8.3.14.1. Company overview
  - 8.3.14.2. Financial performance
  - 8.3.14.3. Product benchmarking
  - 8.3.14.4. Strategic initiatives
- 8.3.15. CERTEST BIOTEC
  - 8.3.15.1. Company overview
  - 8.3.15.2. Financial performance
  - 8.3.15.3. Product benchmarking
  - 8.3.15.4. Strategic initiatives

性感染症（STI）・膣炎用PCR検査の世界市場：市場規模・シェア・動向分析 (症状別・検査の種類別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)

STI And Vaginitis PCR Testing Market Size, Share & Trends Analysis Report By Condition (Sexually Transmitted Infections, Vaginal Infections), By Test Type (STI PCR Panels, Vaginitis PCR Panels), By End-use, By Region, And Segment Forecasts, 2025 - 2030

性感染症・膣炎用PCR検査：市場動向

目次

第1章分析方法・範囲

第2章エグゼクティブサマリー

第3章性感染症・膣炎用PCR検査市場：変動要因・傾向・範囲

第4章性感染症・膣炎用PCR検査市場：症状別の推定・動向分析

第5章性感染症・膣炎用PCR検査市場：検査の種類別の推定・動向分析

第6章性感染症・膣炎用PCR検査市場：最終用途別の推定・動向分析

第7章性感染症・膣炎用PCR検査市場：地域別の推定・動向分析

第8章競合情勢

List of Tables

List of Figures

STI And Vaginitis PCR Testing Market Trends:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. STI and vaginitis PCR testing Market Variables, Trends & Scope

Chapter 4. STI and vaginitis PCR testing Market: Condition Estimates & Trend Analysis

Chapter 5. STI and vaginitis PCR testing Market: Test Type Estimates & Trend Analysis

Chapter 6. STI and vaginitis PCR testing Market: End use Estimates & Trend Analysis

Chapter 7. STI and Vaginitis PCR Testing Market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

性感染症（STI）・膣炎用PCR検査の世界市場：市場規模・シェア・動向分析 (症状別・検査の種類別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)

STI And Vaginitis PCR Testing Market Size, Share & Trends Analysis Report By Condition (Sexually Transmitted Infections, Vaginal Infections), By Test Type (STI PCR Panels, Vaginitis PCR Panels), By End-use, By Region, And Segment Forecasts, 2025 - 2030

性感染症・膣炎用PCR検査：市場動向

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 性感染症・膣炎用PCR検査市場：変動要因・傾向・範囲

第4章 性感染症・膣炎用PCR検査市場：症状別の推定・動向分析

第5章 性感染症・膣炎用PCR検査市場：検査の種類別の推定・動向分析

第6章 性感染症・膣炎用PCR検査市場：最終用途別の推定・動向分析

第7章 性感染症・膣炎用PCR検査市場：地域別の推定・動向分析

第8章 競合情勢

List of Tables

List of Figures

STI And Vaginitis PCR Testing Market Trends:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. STI and vaginitis PCR testing Market Variables, Trends & Scope

Chapter 4. STI and vaginitis PCR testing Market: Condition Estimates & Trend Analysis

Chapter 5. STI and vaginitis PCR testing Market: Test Type Estimates & Trend Analysis

Chapter 6. STI and vaginitis PCR testing Market: End use Estimates & Trend Analysis

Chapter 7. STI and Vaginitis PCR Testing Market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

第1章分析方法・範囲

第2章エグゼクティブサマリー

第3章性感染症・膣炎用PCR検査市場：変動要因・傾向・範囲

第4章性感染症・膣炎用PCR検査市場：症状別の推定・動向分析

第5章性感染症・膣炎用PCR検査市場：検査の種類別の推定・動向分析

第6章性感染症・膣炎用PCR検査市場：最終用途別の推定・動向分析

第7章性感染症・膣炎用PCR検査市場：地域別の推定・動向分析

第8章競合情勢